Broadwood increases STAAR Surgical (STAA) stake with January share buys
Rhea-AI Filing Summary
Broadwood Partners, L.P., a 10% owner of STAAR Surgical Co. (STAA), reported open‑market purchases of the company’s common stock in early January 2026. Broadwood Partners bought 186,946 shares at a weighted average price of $21.0111 and 150,000 shares at $22.3756 on January 6, followed by 66,467 shares at $22.0004 on January 7 and 3,240 shares at $21.9389 on January 8. After these transactions, Broadwood Partners reported holding 15,426,144 shares of STAAR Surgical common stock. A separate holding of 25,900 STAAR Surgical shares is reported as being directly owned by Neal C. Bradsher. The filing notes that Broadwood Capital, Inc. and Neal C. Bradsher may be deemed indirect beneficial owners through their roles with Broadwood Partners, but each disclaims beneficial ownership except to the extent of any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 3,240 | $21.9389 | $71K |
| Purchase | Common Stock | 0 | $0.00 | -- |
| Purchase | Common Stock | 66,467 | $22.0004 | $1.46M |
| Purchase | Common Stock | 0 | $0.00 | -- |
| Purchase | Common Stock | 186,946 | $21.0111 | $3.93M |
| Purchase | Common Stock | 0 | $0.00 | -- |
| Purchase | Common Stock | 150,000 | $22.3756 | $3.36M |
| Purchase | Common Stock | 0 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed to be indirectly beneficially owned by: (i) Broadwood Capital, Inc. ("Broadwood Capital") as General Partner of Broadwood Partners; and (ii) Neal C. Bradsher as President of Broadwood Capital. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. This constitutes the weighted average purchase price. The prices range from $20.92 to $21.09. The Reporting Person will provide upon request by the Securities and Exchange Commission staff (the "SEC Staff"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. This constitutes the weighted average purchase price. The prices range from $21.97 to $22.58. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. This constitutes the weighted average purchase price. The prices range from $21.81 to $22.09. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. This constitutes the weighted average purchase price. The prices range from $21.86 to $21.97. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. These securities are directly owned by Neal C. Bradsher.
FAQ
What insider activity did STAA report in this Form 4 filing?
The Form 4 reports that Broadwood Partners, L.P., a 10% owner of STAAR Surgical Co., purchased additional shares of STAAR Surgical common stock in open‑market transactions on January 6–8, 2026, increasing its reported holdings.
Who are the reporting persons in this STAAR Surgical (STAA) Form 4?
The reporting persons are Broadwood Partners, L.P., Broadwood Capital, Inc., and Neal C. Bradsher. Broadwood Partners directly owns the reported block of shares, while Broadwood Capital and Neal C. Bradsher are listed due to their roles with Broadwood Partners.